305H ProClarity for Pharmacy - PowerPoint PPT Presentation

1 / 40
About This Presentation
Title:

305H ProClarity for Pharmacy

Description:

... such as cost/30-day Rx by month and top 25 drugs by total cost for a quarter. ... Views of specific drug utilization as 30-day Rxs % of drug class or % of all ... – PowerPoint PPT presentation

Number of Views:92
Avg rating:3.0/5.0
Slides: 41
Provided by: veteransaf
Category:

less

Transcript and Presenter's Notes

Title: 305H ProClarity for Pharmacy


1
305H ProClarity for Pharmacy
  • Alan Celestino, R.Ph.
  • Research Pharmacy Specialist
  • Pharmacy Benefits Management Services

2
Learning Objectives
  • Understand how to access ProClarity data cubes
    and have a knowledge of the terminology used
  • Understand how to create custom members and sets
  • Understand how to create views and Briefing Books

3
Learning Objectives (contd)
  • Understand how to export data from ProClarity to
    other Microsoft applications (i.e. Excel /
    PowerPoint)
  • Understand the PBM data cube structure
  • Understand the PBM Briefing Books

4
Organization
  • ProClarity definitions
  • Brief ProClarity UI overview
  • Create custom reports with ProClarity
  • PBM data cube structure
  • PBM Briefing books
  • Create more custom reports based the PBM Briefing
    Books

5
Definitions
6
Definitions
  • Data Cube
  • Collection of data that is organized for rapid
    query response and designed for analysis
  • Derived from relational tables or a data
    warehouse
  • OLAP Client
  • Application that enables browsing and analysis of
    data cubes (e.g. ProClarity)

7
Definitions
  • Briefing Book
  • File that contains saved views (reports)
    organized into folders
  • Interactive and updates automatically
  • Enables those with little or no knowledge of
    ProClarity to view and modify reports
  • ProClarity Analytics Server (PAS)
  • Software that stores briefing books centrally
  • Provides connection to data cubes
  • Enables access with a web browser

8
Definitions
  • Dimension
  • A descriptive category by which the numeric data
    of a cube is analyzed, e.g. Time, Location, Drug
  • The how or by portion of the analysis, e.g.
    by Station by Month by Drug
  • Measure
  • The numeric values you want to analyze
  • The what portion of the analysis, e.g. Total
    Cost, Total Quantity, Total Rxs, etc.

9
Definitions
  • Hierarchy
  • The organization of data within a dimension
    grouped in levels of most general to most
    specific, e.g. All Time, Year, Quarter, Month
  • Level
  • A specific layer in a hierarchy, e.g. Month
  • Member
  • A specific value within a level, e.g. January

10
ProClarity Client
  • ProClarity Enterprise Agreement (EA)
  • Desktop Professional
  • Software (latest version 6.3)
  • Only versions 6.1 or higher work with SQL 2005
    cubes
  • Web Professional
  • Web access (rich client)
  • Software not required
  • Download plug-in if software not installed
  • Same functionality as Desktop Professional
  • Web Standard
  • Web access (thin client)
  • Software not required

11
PBM ProClarity Access
  • VISN Formulary Leader Approval
  • VISN and National access
  • Requests sent to Alan.Celestino_at_va.gov
  • Signed Data Use Agreement must be scanned and
    emailed back and/or mailed back

12
Web Access
13
PBM Data Cube Structure
14
Outpatient Cube Dimensions
  • VISN
  • Nation, VISN, Facility, Clinic
  • Time
  • Fiscal Year, Fiscal Quarter, Month
  • Drug
  • General Class, VA Class, Generic Name, VA Product
  • Complexity
  • Replaced MCG levels

15
Outpatient Cube Dimensions
  • RxType
  • Legend, OTC, Brand, Generic
  • Fill
  • 30-day fill, 60-day fill, 90-day fill
  • Mail/Window
  • CMOP/Local
  • New/Refill/Partial
  • National Formulary
  • Local Formulary

16
Measures Basic
  • Rxs
  • Day30Rxs
  • Unique Patients
  • Day Supply
  • Quantity
  • Cost

17
Measures Calculated
  • Cost/Day
  • Cost/Day30Rx
  • Cost/Unique Patient
  • Cost/Rx
  • Cost/Unit
  • Day30Rxs/Unique Patient
  • Rxs/Unique Patient

18
Measures Calculated
  • Day30RxsAll Drug
  • Day30Rxs for selected drug as a of Day30Rxs for
    all drugs in the Drug dimension.
  • Day30RxsParent
  • Day30Rxs for selected drug as a of Day30Rxs for
    its parent in the Drug dimension.

19
Measures Calculated
  • Unique PatientsAll Drug
  • Unique Patients for selected drug as a of
    Unique Patients for all drugs in the Drug
    dimension.
  • Unique PatientsParent
  • Unique Patients for selected drug as a of
    Unique Patients for its parent in the Drug
    dimension.

20
Measures Calculated
  • RxsAll Drug
  • Actual Rxs for selected drug as a of Actual Rxs
    for all drugs in the Drug dimension.
  • Total CostAll Drug
  • Total Cost for selected drug as a of Total Cost
    for all drugs in the Drug dimension.
  • Dose/Day
  • (QuantityStrength)/Day Supply for oral tablets
    and capsules only

21
Inpatient Cubes
  • Unit Dose cube (PharmacyUD)
  • - Data from April 2004 to present
  • IV cube (PharmacyIV)
  • -Data from October 2002 to present

22
Unit Dose Cube Dimensions
  • VISN
  • Nation, VISN, Facility
  • Time
  • Fiscal Year, Fiscal Quarter, Month
  • Drug
  • General Class, VA Class, Generic Name, VA Product

23
Unit Dose Cube Measures
  • Orders
  • Total Cost
  • Total Qty
  • Unique Patients
  • Cost per Unit

24
IV Cube Dimensions
  • VISN
  • Nation, VISN, Facility
  • Time
  • Fiscal Year, Fiscal Quarter, Month
  • Drug
  • General Class, VA Class, Generic Name, VA
    Product,
  • VA Product Dispensed Unit
  • IV Type
  • Admixture, Chemo, Hyperal, Piggyback, Syringe

25
IV Cube Measures
  • Bags
  • Orders
  • Total Cost
  • Unique Patients
  • Cost/Bag
  • Cost/Unique Patient
  • Cost/Unit
  • Total Qty

26
PBM ProClarityBriefing Books
27
Briefing Books Overview
  • FY08 National Monitors (15 views)
  • Deputy Under Secretary for Health for Operations
    and Management Monitors For FY 2008.
  • Global Measures (25 views)
  • Views of overall drug utilization, such as
    cost/30-day Rx by month and top 25 drugs by total
    cost for a quarter.

28
Briefing Books Overview
  • Drug Utilization (94 views)
  • Views of specific drug utilization as 30-day Rxs
    of drug class or of all drugs as appropriate.
  • Tablet Splitting (28 views)
  • Views of adherence to tablet splitting and
    related measures for specific drugs.
  • Contract Adherence (28 views)
  • Views of adherence to Specific VA Contracts.

29
Drug UtilizationBriefing Book
30
Drug Utilization Views
  • (Drug) Day30Rxs Class
  • (Drug) Day30Rxs All Drug
  • Day30Rxs
  • Corrects for differences in multi-month
    dispensing
  • All Drug
  • Provides a common denominator for comparing
    VISNs/Facilities of different sizes
  • Class
  • Corrects for differences in patient populations

31
Drug Utilization Contents
  • ACEs
  • Alpha Antagonists
  • ARBs
  • Atypical Antipsychotics
  • CCBs
  • COX-2s
  • HMGs
  • NSAHs
  • Ophthalmic Prostaglandins
  • Opioids
  • PDE-5s
  • PPIs
  • SSRIs
  • Triptans
  • TZDs
  • Misc

32
Tablet SplittingBriefing Book
33
Tablet Splitting Formulas
  • Split Rxs
  • Formula ½ tab once daily (qty/days supplylt1)
  • Rxs that are currently being split (exactly in
    half to get the dose)
  • Non-Split Rxs
  • Formula 1 tab once daily (qty/days supply1)
  • Rxs that are not currently being split, but can
    potentially be split (exactly in half to get the
    dose)
  • Splittable Rxs
  • Formula (Split Rxs Non-Split Rxs)
  • Rxs that can potentially be split (exactly in
    half to get the dose)
  • Adherence
  • Formula Split Rxs /(Split Rxs Non-Split Rxs)

34
Tablet Splitting Limitations
  • Must assume all are Once Daily
  • Example Once Daily drug dosed Twice Daily
  • Qty 30, Days Supply 30 (Tablet Splitting)
  • Counts as Non Split
  • Exception Carvedilol
  • Assume all are Twice Daily
  • Similar problem occurs if dosed Once Daily

35
Tablet Splitting Contents
  • Atorvastatin
  • Carvedilol
  • Citalopram
  • Losartan
  • Paroxetine
  • Sertraline
  • Simvastatin

36
Tablet Splitting Views
  • Views are centered around the percent adherence
    to tablet splitting
  • Includes information needed to decide how
    aggressively to pursue a tablet splitting
    strategy
  • Percentage of all Rxs that are splittable
  • e.g. If one drug has 40 of its Rxs splittable
    and another drug has 80 of its Rxs splittable,
    want to pursue drug with more splittable Rxs
  • Savings per Rx by tablet splitting
  • Volume of the drug (from cube)

37
Tablet Splitting Views
  • (Drug) Split Day30RxsSplittable
  • This is Adherence to Tablet Splitting, which is
    Day30Rxs that are currently being split /
    Day30Rxs that can potentially be split (exactly
    in half to get the dose).
  • (Drug) Splittable Day30RxsAll (Drug)
  • Since not all Rxs will be able to be split in
    half to get the desired dose, this shows the
    Day30Rxs that can potentially be split / All
    Day30Rxs for the Drug.

38
Tablet Splitting Views
  • (Drug) Split vs. Non-Split Cost/Day30Rx
  • This shows the Cost/Day30Rx for Split and
    Non-Split Rxs (nationally).
  • (Drug) Cost/Day30Rx Difference
  • This shows the difference (savings) for a Split
    Day30Rx vs. Non-Split Day30Rx (nationally).

39
Future Development
  • ICD-9 Cube
  • Lab Cube
  • Allergy Cube
  • CMOP Costs Cube

40
Miscellaneous
  • OLAP Online Analytical Processing
  • VA ProClarity software download link
    http//vhaaacapp3.vha.med.va.gov/proclarityea/
  • MDX Reference book Fast Track to MDX
Write a Comment
User Comments (0)
About PowerShow.com